Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy.
Colominas-González E, De Antonio M, Masip M, Martin Conde MT, Cardona G, Fresán Restituto D, Comas D, Roch MA, López B, Torres-Bondia FI, Retamero A, Knobel H, Luque S. Colominas-González E, et al. Among authors: de antonio m. Eur J Hosp Pharm. 2024 May 27:ejhpharm-2024-004118. doi: 10.1136/ejhpharm-2024-004118. Online ahead of print. Eur J Hosp Pharm. 2024. PMID: 38802166
Pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections.
Fresan D, Luque S, Benítez-Cano A, Sorlí L, Milagro Montero M, De-Antonio M, Prim N, Vega V, Horcajada JP, Grau S. Fresan D, et al. Among authors: de antonio m. J Antimicrob Chemother. 2023 Mar 2;78(3):678-683. doi: 10.1093/jac/dkac439. J Antimicrob Chemother. 2023. PMID: 36626402
Real-world experience of therapeutic drug monitoring and PK/PD achievement of ceftaroline administered by different infusion regimens in patients with confirmed infections caused by Gram-positive bacteria.
Fresán D, Luque S, Benítez-Cano A, Sorlí L, Montero MM, De-Antonio M, Vega V, Roberts JA, Horcajada JP, Grau S. Fresán D, et al. Among authors: de antonio m. J Antimicrob Chemother. 2023 Dec 1;78(12):2810-2815. doi: 10.1093/jac/dkad296. J Antimicrob Chemother. 2023. PMID: 37823445
Multidisciplinary medication review during older patient hospitalization according to STOPP/START criteria reduces potentially inappropriate prescriptions: MoPIM cohort study.
Ortonobes S, Herranz S, Lleal M, Sevilla-Sánchez D, Jordana R, Mascaró O, Ferrández O, de Jaime E, Estrada R, Nazco GJ, Baré M; MoPIM Study Group. Ortonobes S, et al. BMC Geriatr. 2024 Jul 8;24(1):584. doi: 10.1186/s12877-024-05185-w. BMC Geriatr. 2024. PMID: 38978009 Free PMC article.
Comprehensive Multimorbidity Patterns in Older Patients Are Associated with Quality Indicators of Medication-MoPIM Cohort Study.
Lleal M, Baré M, Ortonobes S, Sevilla-Sánchez D, Jordana R, Herranz S, Gorgas MQ, Espaulella-Ferrer M, Arellano M, de Antonio M, Nazco GJ, Hernández-Luis R, On Behalf Of The MoPIM Study Group. Lleal M, et al. Among authors: de antonio m. Int J Environ Res Public Health. 2022 Nov 29;19(23):15902. doi: 10.3390/ijerph192315902. Int J Environ Res Public Health. 2022. PMID: 36497976 Free PMC article.
Colchicine in acutely decompensated heart failure: the COLICA trial.
Pascual-Figal D, Núñez J, Pérez-Martínez MT, González-Juanatey JR, Taibo-Urquia M, Llàcer Iborra P, Delgado J, Villar S, Mirabet S, Aimo A, Riquelme-Pérez A, Anguita Sánchez M, Martínez-Sellés M, Noguera-Velasco JA, Ibáñez B, Bayés-Genís A; COLICA investigators. Pascual-Figal D, et al. Eur Heart J. 2024 Aug 30;45(45):4826-36. doi: 10.1093/eurheartj/ehae538. Online ahead of print. Eur Heart J. 2024. PMID: 39211951 Free PMC article.
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial.
Guièze R, Ysebaert L, Roos-Weil D, Fornecker LM, Ferrant E, Molina L, Aurran T, Clavert A, de Guibert S, Michallet AS, Saad A, Drénou B, Quittet P, Hivert B, Laribi K, Gay J, Quinquenel A, Broseus J, Rouille V, Schwartz D, Magnin B, Lazarian G, Véronèse L, de Antonio M, Laurent C, Tournilhac O, Pereira B, Feugier P. Guièze R, et al. Among authors: de antonio m. Nat Commun. 2024 Aug 9;15(1):6822. doi: 10.1038/s41467-024-51264-2. Nat Commun. 2024. PMID: 39122717 Free PMC article. Clinical Trial.
Bulbar muscle impairment in patients with late onset Pompe disease: Insight from the French Pompe registry.
Retailleau E, Lefeuvre C, De Antonio M, Bouhour F, Tard C, Salort-Campana E, Lagrange E, Béhin A, Solé G, Noury JB, Sacconi S, Magot A, Pakleza AN, Orlikowski D, Beltran S, Spinazzi M, Cintas P, Fournier M, Bouibede F, Prigent H, Nicolas G, Taouagh N, El Guizani T, Attarian S, Arrassi A, Hamroun D, Laforêt P. Retailleau E, et al. Among authors: de antonio m. Eur J Neurol. 2024 Oct;31(10):e16428. doi: 10.1111/ene.16428. Epub 2024 Aug 7. Eur J Neurol. 2024. PMID: 39109844 Free PMC article.
Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA).
Pascual-Figal D, Núñez Villota J, Pérez-Martínez MT, González-Juanatey JR, Taibo-Urquía M, Llàcer Iborra P, González-Martín J, Villar S, Soler M, Mirabet S, Aimo A, Riquelme-Pérez A, Anguita Sánchez M, Martínez-Sellés M, Sánchez PL, Ibáñez B, Bayés-Genís A;  on behalf of the COLICA Investigators (see Appendix). Pascual-Figal D, et al. Eur J Heart Fail. 2024 Sep;26(9):1999-2007. doi: 10.1002/ejhf.3300. Epub 2024 Jun 4. Eur J Heart Fail. 2024. PMID: 38837516 Clinical Trial.
123 results